Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the efficacy of cetuximab in combination with
chemotherapy in comparison to chemotherapy alone in patients with advanced non small cell
lung cancer who did not received prior chemotherapy. Overall survival will be taken as
primary measure of efficacy.